Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Current Assets (2016 - 2025)

Editas Medicine (EDIT) has disclosed Current Assets for 11 consecutive years, with $176.9 million as the latest value for Q3 2025.

  • Quarterly Current Assets fell 34.76% to $176.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $176.9 million through Sep 2025, down 34.76% year-over-year, with the annual reading at $289.3 million for FY2024, 15.11% down from the prior year.
  • Current Assets for Q3 2025 was $176.9 million at Editas Medicine, down from $182.8 million in the prior quarter.
  • The five-year high for Current Assets was $632.3 million in Q1 2021, with the low at $176.9 million in Q3 2025.
  • Average Current Assets over 5 years is $382.5 million, with a median of $356.8 million recorded in 2022.
  • The sharpest move saw Current Assets surged 48.74% in 2021, then tumbled 36.16% in 2025.
  • Over 5 years, Current Assets stood at $507.3 million in 2021, then dropped by 29.68% to $356.8 million in 2022, then fell by 4.46% to $340.8 million in 2023, then fell by 15.11% to $289.3 million in 2024, then plummeted by 38.86% to $176.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $176.9 million, $182.8 million, and $224.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.